Secretion of pro-inflammatory molecules by CD4+ T cells—as observed in T1D, vaccine, and tuberculosis models—activates and increases the proliferation, survival, and cytotoxic ability of CD8+ T cells (31–33). Here, CD4 is linked to type 1 diabetes mellitus.